Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Pressure BioSciences, Inc.    PBIO

SummaryNewsCalendarCompanyFinancialsConsensus 
News SummaryMost relevantAll newsSector news 

PRESSURE BIOSCIENC : Pressure BioSciences, Inc. to Discuss Third Quarter 2008 Financial Results and Provide Business Update

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/14/2008 | 10:15pm CEST

SOUTH EASTON, Mass., Nov. 14 /PRNewswire-FirstCall/ -- Pressure BioSciences, Inc. (Nasdaq: PBIO) today announced that the Company will host a teleconference to discuss its third quarter 2008 financial results and to provide a business update. Anyone interested may listen to the teleconference either by telephone or through a live web-cast. The teleconference and web-cast information is provided below:

Date: Monday, November 17, 2008

Time: 4:30 p.m. Eastern Standard Time (EST)

To attend this teleconference via web-cast, please go to the Company's website: www.pressurebiosciences.com

    To attend this teleconference via telephone:
    Dial-in: (800) 344-6491
    Participant code: 3034253

For those unable to participate in the live teleconference, a replay will be available approximately one hour after the call ends, and will be accessible through the Company's website.

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (PBI) is a publicly-traded company focused on the development of a novel, enabling technology called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio-molecular interactions. PBI currently holds 13 US and 6 foreign patents covering multiple applications of PCT in the life sciences' field, including such areas as genomic and proteomic sample preparation, pathogen inactivation, the control of chemical reactions, immunodiagnostics, and protein purification.

    Investor Contacts:
    Richard T. Schumacher, President & CEO
    Edward H. Myles, Senior Vice President of Finance & CFO
    Pressure BioSciences, Inc.
    (T) 508-230-1828

SOURCE Pressure BioSciences, Inc.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on PRESSURE BIOSCIENCES, INC.
06/02 STOCKNEWSNOW.COM : Publishes Business and Earnings Review Q1 2016 with Pressure ..
06/01 WALLSTREET RESEARCH(TM) ANNOUNCES AV : Pbio)
05/26 SEETHRUEQUITY ISSUES UPDATE ON PRESS : PBIO), Raises Price Target to $1.75
05/25 SECFILINGS.COM : Reports on Pressure BioSciences' Q1 2016 Financial Results
05/19 PRESSURE BIOSCIENCES : Reports First Quarter 2016 Financial Results and Provides..
04/14 PRESSURE BIOSCIENCES INC : Why Pressure BioSciences' (PBIO) Addition to the Rich..
04/06 PRESSURE BIOSCIENCES : Reports Fiscal Year 2015 Financial Results and Provides B..
03/14 PRESSURE BIOSCIENCES : to Participate in SCIEX Workshop on New Innovations Towar..
03/07 PRESSURE BIOSCIENCES : Entry into a Material Definitive Agreement, Unregistered ..
02/18 PRESSURE BIOSCIENCES INC : Recent SCIEX Agreement Already Starting to Pay Big Di..
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
09:58a Weak China sales drag down Smith & Nephew profits
07/27DJAlere Faces Criminal Probe Over Medicare, Medicaid Billing
07/26DJBAXTER : Results Boosted by Growth in Hospital Products Segment
07/25DJBAXTER : CFOs Turn to Consultants as Challenges Mount
07/22DJDEXCOM : Shares Rise After FDA Panel Vote
More sector news : Medical Equipment, Supplies & Distribution - NEC